Summit Therapeutics (SMMT) Receivables Refunds (2016 - 2024)
Historic Receivables Refunds for Summit Therapeutics (SMMT) over the last 9 years, with Q4 2024 value amounting to $557000.0.
- Summit Therapeutics' Receivables Refunds fell 3431.6% to $557000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $557000.0, marking a year-over-year decrease of 3431.6%. This contributed to the annual value of $557000.0 for FY2024, which is 3431.6% down from last year.
- According to the latest figures from Q4 2024, Summit Therapeutics' Receivables Refunds is $557000.0, which was down 3431.6% from $660000.0 recorded in Q3 2024.
- Over the past 5 years, Summit Therapeutics' Receivables Refunds peaked at $15.7 million during Q4 2021, and registered a low of $557000.0 during Q4 2024.
- Moreover, its 5-year median value for Receivables Refunds was $6.3 million (2020), whereas its average is $7.1 million.
- Its Receivables Refunds has fluctuated over the past 5 years, first surged by 11725.56% in 2021, then tumbled by 9373.36% in 2023.
- Summit Therapeutics' Receivables Refunds (Quarter) stood at $9.9 million in 2020, then skyrocketed by 59.24% to $15.7 million in 2021, then tumbled by 63.26% to $5.8 million in 2022, then plummeted by 85.29% to $848000.0 in 2023, then plummeted by 34.32% to $557000.0 in 2024.
- Its Receivables Refunds stands at $557000.0 for Q4 2024, versus $660000.0 for Q3 2024 and $953000.0 for Q2 2024.